Related Editorial
In a country where the life-threatening risks of smoking are well-known and 22 million smokers want to quit, a milestone agreement between a drug delivery platform innovator and one of the world’s largest producers and marketers of tobacco and cigarettes may offer tobacco users an alternative method of satisfying their needs along with greatly reduced risk.
- The quest for other alternatives to cigarettes has brought Big Tobacco to the door of biotech company Lexaria.
- The bioscience potential for nicotine delivery cannot be ignored and may deliver myriad benefits.
- Lexaria’s proprietary DehydraTECH technology makes the company an ideal partner.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) (LXRP Profile) has announced that its wholly owned subsidiary Lexaria Nicotine LLC and one of the world’s largest tobacco companies have executed a definitive agreement to pursue innovation in oral, reduced-risk nicotine consumer products using Lexaria’s patented DehydraTECH™ technology. Other tobacco companies are also exploring alternative options for smokers. British American Tobacco Industries (NYSE: BTI) (OTC: BTAFF) is exploring vaping and using the move away from cigarettes to bolster its public image. Philip Morris International Inc. (NYSE: PM) has been campaigning to get international support for alternatives to cigarettes as well as developing its own alternatives, including heating tobacco. And Imperial Brands PLC ADR (OTCQX: IMBBF) (OTCQX: IMBBY) has established a stake in a cannabis biotech company as it explores the options for this alternative drug.
To view the full editorial, visit http://nnw.fm/Gg2cN
About Lexaria Bioscience Corp.
Lexaria Bioscience Corp. has developed and out-licenses its disruptive delivery technology that promotes healthier ingestion methods, lower overall dosing and quicker onset of lipophilic active molecules. Lexaria has ten patents granted in the USA and in Australia and has filed over 50 patent applications worldwide across ten patent families. Lexaria’s technology provides more rapid delivery to the bloodstream; and important taste-masking benefits, for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs), nicotine and other molecules. Lexaria Nicotine LLC is a United States domiciled, majority-owned subsidiary of Lexaria Bioscience Corp., focused on reduced-risk nicotine solutions www.LexariaNicotineco.com. For more information, visit the company’s website at www.LexariaBioscience.com.
About NetworkNewsAudio
NetworkNewsAudio, a service of NetworkNewsWire (NNW), allows you to sit back and listen to market updates, interviews and company press releases. NetworkNewsAudio keeps you informed on publicly traded companies we’re watching. The audio clips provide snapshots of position, opportunity and momentum. NetworkNewsAudio is a Brand Awareness Distribution Solution from NetworkNewsWire.
For more information, visit www.NetworkNewsAudio.com
About NetworkNewsWire
NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
Editor@NetworkNewsWire.com
